Advertisement

Phosphorus-Containing Inhibitors of Proteolytic Enzymes

  • Angela Stöckel-Maschek
  • Beate Stiebitz
  • Bianca Senns
  • Nils Lindner
  • Werner Mögelin
  • Klaus Neubert
Conference paper
Part of the Advances in Experimental Medicine and Biology book series (volume 575)

Keywords

Inhibition Constant Phosphonic Acid Micromolar Range Dipeptidyl Peptidase Amino Acid Amide 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Born I, Faust J, Heins J, Barth A, Neubert K, 1994, Potent inhibitors of dipeptidyl peptidase IV. Eur Cell Biol. Suppl. 40: 83.Google Scholar
  2. Cushman DW, Cheung HS, Sabo EF, Ondetti MA, 1977, Design of potent competitive inhibitors of angiotensin-converting enzyme. Carboxyalkanoyl and mercaptoalkanoyl amino acids. Biochemistry. 16: 5484–5491.CrossRefPubMedGoogle Scholar
  3. Lambeir AM, Durinx C, Scharpe S, De Meester I, 2003, Dipeptidyl-peptidase IV from bench to bedside: An update on structural properties, functions, and clinical aspects of the enzyme DPP IV. Crit Rev Clin Lab Sci. 40: 209–294.PubMedGoogle Scholar
  4. Kitamura S-I, Carbini, LA, Maggiora LL, Simmons WH, Scicli AG, 1995, Potentiation by aminopeptidase P of blood pressure response to bradykinin. Br J Pharmacol. 114: 6–7.PubMedGoogle Scholar
  5. Maggiora LL, Orawski AT, Simmons WH, 1999, Apstatin analogue inhibitors of aminopeptidase P, a bradykinin-degrading enzyme. J Med Chem. 42: 2394–2402.CrossRefPubMedGoogle Scholar
  6. Morrison JF, Walsh CT, 1988, The behavior and significance of slow-binding enzym inibitors. Adv Enzymol. 61: 201–301.PubMedGoogle Scholar
  7. Nishizawa R, Saino T, Takita T, Suda H, Aoyagi T, 1977, Synthesis and structure-activity relations of bestatin-analogs, inhibitors of aminopeptidase B. J Med Chem. 20: 510–515.CrossRefPubMedGoogle Scholar
  8. Oleksyszyn J, Subotkowska L, Mastalerz P, 1979, Diphenyl 1-aminoalkanephosphonates. Synthesis 985–986.Google Scholar
  9. Patel DV, Rielly-Gauvin K, Ryono DE, 1990, Preparation of peptidic α-hydroxy phosphonates a new class of transition state analog renin inhibitors. Tetrahedron Lett. 31: 5587–5590.CrossRefGoogle Scholar
  10. Prechel MM, Orawski AT, Maggiora LL, Simmons WH, 1995, Effect of a new aminopeptidase P inhibitor, apstatin, on bradykinin degradation in the rat lung. J Pharmacol Exp Ther. 275: 1136–1142.PubMedGoogle Scholar
  11. Rahfeld J-U., 1989, Beiträge zur klinischen Charakterisierung der Dipeptidyl Peptidase IV, dissertation, Martin-Luther-Universität Halle-Wittenberg, pp 56–57.Google Scholar
  12. Rich DH, Moon BJ, Harbeson S, 1984, Inhibition of aminopeptidases of by amastatin and bestatin derivates. Effect of inhibitor structure on slow-binding processes. J Med Chem. 27: 417–422.CrossRefPubMedGoogle Scholar
  13. Segel IH, 1993, Enzyme kinetics. Behavior and analysis of rapid equilibrium and steady-state enzyme systems, John Wiley & Sons, Inc., Wiley Classics Library, pp 161–226.Google Scholar
  14. Stöckel A, Stiebitz B, Neubert K, 1997, Specific inhibitors of aminopeptidase P. Peptides and pseudopeptides of 2-hydroxy-3-amino acids. in Cellular Peptidases in Immune Functions and Diseases, Adv Exp Med Biol. (Ansorge, S., Langner, J., eds.), pp. 31–34, Plenum Press, New York.Google Scholar
  15. Stöckel-Maschek A, Mrestani-Klaus C, Stiebitz B, Demuth H-U, Neubert K, 2000a, Thioxo amino acid pyrrolidides and thiazolidides: new inhibitors of proline specific peptidases. Biochim Biophys Acta. 1479: 15–31.PubMedGoogle Scholar
  16. Stöckel-Maschek A, Stiebitz B, Born I, Faust J, Mögelin W, Neubert K, 2000b, Potent inhibitors of dipeptidyl peptidase IV and their mechanisms of inhibition. Adv Exp Med Biol. 477: 117–123.PubMedGoogle Scholar
  17. Stöckel-Maschek A, Stiebitz B, Koelsch R, Neubert K, 2003, A continuous fluorimetric assay for aminopeptidase P: Detailed analysis of product inhibition. Anal Biochem. 322: 60–67.CrossRefPubMedGoogle Scholar
  18. Stöckel-Maschek A, Stiebitz B, Neubert K, Novel 3-amino-2-hydroxy acids containing protease inhibitors: II. Inhibition of different metallopeptidases and proline-specific serine proteases. in preparation.Google Scholar
  19. Szedlacsek SE, Duggleby RG, 1995, Kinetics of slow and tight-binding inhibitors. Methods Enzymol. 249: 144–180.PubMedCrossRefGoogle Scholar
  20. Umezawa K, Aoyagi T, Suda H, Hamada M, Takeuchi T, 1976, Bestatin, an inhibitor of aminopeptidas B, produced by actinomycetes. J Antibiot. 29: 97–99.PubMedGoogle Scholar
  21. Yoshimoto T, Tone H, Honda T, Osatomi K, Kobayashi R, Tsuru D, 1989, Sequencing and and high expression of aminopeptidase P gene from Escherichia coli HB101. J Biochem. 105: 412–416.PubMedGoogle Scholar
  22. Wolf B, Fischer G, Barth A, 1978, Kinetische Untersuchungen an der Dipeptidyl-peptidase IV. Acta Biol Med Germ. 37: 409–420.PubMedGoogle Scholar
  23. Xu Y, Wellner D, Scheinberg DA, 1995, Substance P and bradykinin are natural inhibitors of CD13/aminopeptidase N. Biochem Biophys Res Commun. 208: 664–674.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, Inc. 2006

Authors and Affiliations

  • Angela Stöckel-Maschek
    • 1
  • Beate Stiebitz
    • 1
  • Bianca Senns
    • 1
  • Nils Lindner
    • 1
  • Werner Mögelin
    • 1
  • Klaus Neubert
    • 1
  1. 1.Department of Biochemistry and BiotechnologyMartin-Luther-University Halle-WittenbergHalleGermany

Personalised recommendations